FTC Complaint: Shire ViroPharma Filed Baseless Claims to Block Generic Competition By Sam | February 7, 2017 A complaint from the Federal Trade Commission alleges Shire ViroPharma unlawfully stifled competition for its branded drugs. Source: Drug Industry Daily Posted in Drug Industry Daily